Saito Miho, Hirai Chihiro, Makino Shintaro, Takeda Jun, Nojiri Shuko, Takeda Satoru, Itakura Atsuo
Department of Obstetrics and Gynecology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Medical Technology Innovation Center Clinical Research and Trial Center, Juntendo University Faculty of Medicine, Tokyo, Japan.
JMA J. 2020 Apr 15;3(2):125-130. doi: 10.31662/jmaj.2019-0072. Epub 2020 Apr 6.
To clarify the usefulness of glucose challenge test (GCT), the rate of gestational diabetes mellitus (GDM) detection and perinatal outcomes were compared between the groups of random blood glucose level (RBG) and 50 g GCT in this study.
The first survey was conducted at 255 institutions registered by the Kanto Society of Obstetrics and Gynecology and clinical training institutions in the Kanto Area, followed by a second survey. The included women were broadly classified into the RBG and GCT groups, according to the mid-trimester blood glucose screening method, and the perinatal outcomes of the two groups were retrospectively compared. The primary outcomes were the proportion of infants weighing 3,500 g or more and birth weight ≥90-percentile infants.
The rate of GDM diagnosis was significantly higher in the GCT group (7.6%) than that in the RBG group (4.8%). However, no significant differences were observed in perinatal outcomes, i.e., the proportion of infants weighing 3,500 g or more or birth weight ≥90 percentile.
GCT is not superior for predicting infants weighing 3,500 g or more and birth weight ≥90 percentile, as compared with RBG.
为阐明葡萄糖耐量试验(GCT)的效用,本研究比较了随机血糖水平(RBG)组和50克葡萄糖耐量试验组的妊娠期糖尿病(GDM)检出率及围产期结局。
首次调查在关东地区妇产科协会注册的255家机构及临床培训机构进行,随后进行了第二次调查。根据孕中期血糖筛查方法,将纳入的女性大致分为RBG组和GCT组,并对两组的围产期结局进行回顾性比较。主要结局指标为体重≥3500克的婴儿比例及出生体重≥第90百分位数的婴儿。
GCT组的GDM诊断率(7.6%)显著高于RBG组(4.8%)。然而,在围产期结局方面,即体重≥3500克的婴儿比例或出生体重≥第90百分位数方面,未观察到显著差异。
与RBG相比,GCT在预测体重≥3500克的婴儿及出生体重≥第90百分位数方面并无优势。